CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.005
+0.095 (4.97%)
Sep 18, 2026, 4:08 PM HKT

CANbridge Pharmaceuticals Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
88.166.6310.5137.49463.11745.82
Cash & Short-Term Investments
88.166.6310.5137.49463.11745.82
Cash Growth
4394.80%534.40%-92.36%-70.31%-37.91%106.71%
Accounts Receivable
10.8515.1216.7231.2319.059.14
Other Receivables
-7.479.878.29-18.76
Receivables
10.8522.5826.5939.5219.0527.9
Inventory
23.1720.577.98.789.8213.45
Other Current Assets
21.490.390.3624.0813.1824.54
Total Current Assets
143.62110.1745.35209.86505.16811.71
Property, Plant & Equipment
0.650.513.64109.01144.7229.54
Other Intangible Assets
48.1154.7167.8276.4949.0151.27
Other Long-Term Assets
----3.16-
Total Assets
192.38165.39116.81395.36702.05892.52

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
237.86368.83370.46198.05107.5443.61
Accrued Expenses
-60.7668.763.46114.9893.82
Current Portion of Long-Term Debt
197.0315.3323.6926.8730.87
Current Portion of Leases
0.660.9111.7611.0313.037.88
Current Unearned Revenue
2.92.73----
Other Current Liabilities
76.5815.0816.3731.7115.699.6
Total Current Liabilities
337455.34482.61327.95278.11185.78
Long-Term Debt
9815.046.6310.78-
Long-Term Leases
0.140.1493.65100.58104.6113.35
Long-Term Unearned Revenue
42.1743.66----
Total Liabilities
388.31507.15591.3435.15393.49199.13

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.040.030.030.030.030.03
Additional Paid-In Capital
-3,5883,4743,4733,4713,471
Retained Earnings
--4,189-4,210-3,789-3,411-2,927
Comprehensive Income & Other
-195.97259.01261.79276.55247.88149.89
Shareholders' Equity
-195.93-341.76-474.49-39.79308.56693.39
Total Liabilities & Equity
192.38165.39116.81395.36702.05892.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
28.8116.08135.78141.93155.2852.1
Net Cash (Debt)
59.2950.54-125.28-4.44307.83693.71
Net Cash Growth
-----55.63%-
Net Cash Per Share
0.110.11-0.29-0.010.737.36
Filing Date Shares Outstanding
597.44511.12424.56424.56424.29424.19
Total Common Shares Outstanding
597.44511.12424.56424.56424.29424.19
Working Capital
-193.38-345.17-437.26-118.08227.06625.93
Book Value Per Share
-0.33-0.67-1.12-0.090.731.63
Tangible Book Value
-244.04-396.47-542.31-116.28259.54642.12
Tangible Book Value Per Share
-0.41-0.78-1.28-0.270.611.51
Machinery
-9.4610.6816.5813.544.79
Leasehold Improvements
-1.941.943.9410.8611.32